- Home
- CUE vs MFM Comparison
CUE vs MFM Comparison
Compare CUE & MFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CUE | MFM |
|---|---|---|
| Founded | 2014 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance Companies |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.5M | 224.5M |
| IPO Year | 2017 | N/A |
Fundamental Metrics
Financial Performance| Metric | CUE | MFM |
|---|---|---|
| Price | $28.95 | $5.41 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $120.00 | N/A |
| AVG Volume (30 Days) | 202.0K | ★ 267.5K |
| Earning Date | 05-13-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.08% |
| EPS Growth | ★ 61.11 | N/A |
| EPS | N/A | ★ 0.03 |
| Revenue | ★ $27,466,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $179.67 |
| Revenue Growth | ★ 195.75 | N/A |
| 52 Week Low | $0.17 | $5.13 |
| 52 Week High | $45.50 | $5.67 |
Technical Indicators
Market Signals| Indicator | CUE | MFM |
|---|---|---|
| Relative Strength Index (RSI) | 52.45 | 46.58 |
| Support Level | $24.70 | $5.34 |
| Resistance Level | $33.95 | $5.48 |
| Average True Range (ATR) | 3.76 | 0.05 |
| MACD | 0.19 | 0.00 |
| Stochastic Oscillator | 53.77 | 38.24 |
Price Performance
Historical ComparisonAbout CUE Cue Biopharma Inc.
Cue Biopharma Inc is a clinical-stage therapeutics company focused on advancing a robust portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its product pipeline includes CUE-221, an anti-IgE antibody candidate being developed for allergic diseases. The company has also developed the Immuno-STAT platform for targeting disease-related T cells and is developing CUE-401, an IL-2 and TGF-B therapeutic candidate for autoimmune diseases.
About MFM MFS Municipal Income Trust
MFS Municipal Income Trust is a diversified closed-end management investment company. Its investment objective is to seek high current income exempt from federal income tax, but it may also consider capital appreciation. The fund invests a majority of its net assets, including assets attributable to preferred shares and borrowings for investment purposes, in municipal bonds.